- Home
- VKTX vs ALVO Comparison
VKTX vs ALVO Comparison
Compare VKTX & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- ALVO
- Stock Information
- Founded
- VKTX 2012
- ALVO 2013
- Country
- VKTX United States
- ALVO Luxembourg
- Employees
- VKTX N/A
- ALVO N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- VKTX Health Care
- ALVO Health Care
- Exchange
- VKTX Nasdaq
- ALVO Nasdaq
- Market Cap
- VKTX 3.4B
- ALVO 3.4B
- IPO Year
- VKTX 2015
- ALVO N/A
- Fundamental
- Price
- VKTX $24.15
- ALVO $9.67
- Analyst Decision
- VKTX Strong Buy
- ALVO Buy
- Analyst Count
- VKTX 11
- ALVO 1
- Target Price
- VKTX $95.18
- ALVO $18.00
- AVG Volume (30 Days)
- VKTX 3.8M
- ALVO 116.9K
- Earning Date
- VKTX 04-23-2025
- ALVO 03-26-2025
- Dividend Yield
- VKTX N/A
- ALVO N/A
- EPS Growth
- VKTX N/A
- ALVO N/A
- EPS
- VKTX N/A
- ALVO N/A
- Revenue
- VKTX N/A
- ALVO $491,978,000.00
- Revenue This Year
- VKTX N/A
- ALVO $399.41
- Revenue Next Year
- VKTX N/A
- ALVO $41.44
- P/E Ratio
- VKTX N/A
- ALVO N/A
- Revenue Growth
- VKTX N/A
- ALVO 426.85
- 52 Week Low
- VKTX $23.27
- ALVO $9.15
- 52 Week High
- VKTX $82.00
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- VKTX 33.93
- ALVO 27.07
- Support Level
- VKTX $25.80
- ALVO $11.07
- Resistance Level
- VKTX $29.60
- ALVO $11.77
- Average True Range (ATR)
- VKTX 1.61
- ALVO 0.42
- MACD
- VKTX -0.30
- ALVO -0.13
- Stochastic Oscillator
- VKTX 10.72
- ALVO 17.00
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.